These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 27630331)

  • 1. Prediction of KRAS Mutation in Rectal Cancer Using MRI.
    Shin YR; Kim KA; Im S; Hwang SS; Kim K
    Anticancer Res; 2016 Sep; 36(9):4799-804. PubMed ID: 27630331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterizing MRI features of rectal cancers with different KRAS status.
    Xu Y; Xu Q; Ma Y; Duan J; Zhang H; Liu T; Li L; Sun H; Shi K; Xie S; Wang W
    BMC Cancer; 2019 Nov; 19(1):1111. PubMed ID: 31727020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of KRAS mutation as predictor of pathologic response after neoadjuvant chemoradiation therapy for rectal cancer.
    Martellucci J; Alemanno G; Castiglione F; Bergamini C; Valeri A
    Updates Surg; 2015 Mar; 67(1):47-53. PubMed ID: 25702261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparative Evaluation of the Value of Quantitative Parameters of Dual-energy CT and MRI for KRAS Mutation in Rectal Cancer].
    Lin XQ; Han T; Jing MY; Deng LN; Zhang B; Zhou JL
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2022 Aug; 44(4):606-613. PubMed ID: 36065693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KRAS Mutant Status, p16 and β-catenin Expression May Predict Local Recurrence in Patients Who Underwent Transanal Endoscopic Microsurgery (TEMS) for Stage I Rectal Cancer.
    Sideris M; Moorhead J; Diaz-Cano S; Bjarnason I; Haji A; Papagrigoriadis S
    Anticancer Res; 2016 Oct; 36(10):5315-5324. PubMed ID: 27798894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility of MRI Radiomics for Predicting KRAS Mutation in Rectal Cancer.
    Guo XF; Yang WQ; Yang Q; Yuan ZL; Liu YL; Niu XH; Xu HB
    Curr Med Sci; 2020 Dec; 40(6):1156-1160. PubMed ID: 33428144
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Sideris M; Moorhead J; Diaz-Cano S; Haji A; Papagrigoriadis S
    Anticancer Res; 2017 Mar; 37(3):1349-1357. PubMed ID: 28314302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterogeneity of KRAS Mutation Status in Rectal Cancer.
    Jo P; König A; Schirmer M; Kitz J; Conradi LC; Azizian A; Bernhardt M; Wolff HA; Grade M; Ghadimi M; Ströbel P; Schildhaus HU; Gaedcke J
    PLoS One; 2016; 11(4):e0153278. PubMed ID: 27064574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetic Resonance-Based Texture Analysis Differentiating KRAS Mutation Status in Rectal Cancer.
    Oh JE; Kim MJ; Lee J; Hur BY; Kim B; Kim DY; Baek JY; Chang HJ; Park SC; Oh JH; Cho SA; Sohn DK
    Cancer Res Treat; 2020 Jan; 52(1):51-59. PubMed ID: 31096736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Deep Learning Model Based on MRI and Clinical Factors Facilitates Noninvasive Evaluation of KRAS Mutation in Rectal Cancer.
    Liu H; Yin H; Li J; Dong X; Zheng H; Zhang T; Yin Q; Zhang Z; Lu M; Zhang H; Wang D
    J Magn Reson Imaging; 2022 Dec; 56(6):1659-1668. PubMed ID: 35587946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative analysis of real-time quantitative PCR-Sanger sequencing method and TaqMan probe method for detection of KRAS/BRAF mutation in colorectal carcinomas].
    Zhang X; Wang Y; Gao N; Wang J
    Zhonghua Bing Li Xue Za Zhi; 2014 Feb; 43(2):77-82. PubMed ID: 24742565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mutations of KRAS and BRAF in Chinese patients with colorectal carcinoma: analyses of 966 cases].
    Gao J; Sun ZW; Li YY; Shen L
    Zhonghua Bing Li Xue Za Zhi; 2012 Sep; 41(9):579-83. PubMed ID: 23157823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KRAS mutations and CDKN2A promoter methylation show an interactive adverse effect on survival and predict recurrence of rectal cancer.
    Kohonen-Corish MR; Tseung J; Chan C; Currey N; Dent OF; Clarke S; Bokey L; Chapuis PH
    Int J Cancer; 2014 Jun; 134(12):2820-8. PubMed ID: 24259266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Locally advanced rectal cancers with simultaneous occurrence of KRAS mutation and high VEGF expression show invasive characteristics.
    Krajnović M; Marković B; Knežević-Ušaj S; Nikolić I; Stanojević M; Nikolić V; Šiljić M; Jovanović Ćupić S; Dimitrijević B
    Pathol Res Pract; 2016 Jul; 212(7):598-603. PubMed ID: 27184911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KRAS mutation status concordance between the primary tumor and the corresponding metastasis in patients with rectal cancer.
    Jo P; Bernhardt M; Nietert M; König A; Azizian A; Schirmer MA; Grade M; Kitz J; Reuter-Jessen K; Ghadimi M; Ströbel P; Schildhaus HU; Gaedcke J
    PLoS One; 2020; 15(10):e0239806. PubMed ID: 33002027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PIK3CA mutations predict local recurrences in rectal cancer patients.
    He Y; Van't Veer LJ; Mikolajewska-Hanclich I; van Velthuysen ML; Zeestraten EC; Nagtegaal ID; van de Velde CJ; Marijnen CA
    Clin Cancer Res; 2009 Nov; 15(22):6956-62. PubMed ID: 19903786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Editorial for "A Deep Learning Model Based on MRI and Clinical Factors Facilitates Noninvasive Prediction of KRAS Mutation in Rectal Cancer".
    Fernandes MC; Horvat N
    J Magn Reson Imaging; 2022 Dec; 56(6):1669-1670. PubMed ID: 35575434
    [No Abstract]   [Full Text] [Related]  

  • 18. Reappraisal of K-ras and p53 gene mutations in the recurrence of Dukes' B2 rectal cancer after curative resection.
    Liang JT; Cheng YM; Chang KJ; Chien CT; Hsu HC
    Hepatogastroenterology; 1999; 46(26):830-7. PubMed ID: 10370622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stage III & IV colon and rectal cancers share a similar genetic profile: a review of the Oregon Colorectal Cancer Registry.
    Gawlick U; Lu KC; Douthit MA; Diggs BS; Schuff KG; Herzig DO; Tsikitis VL
    Am J Surg; 2013 May; 205(5):608-12; discussion 612. PubMed ID: 23592171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EUS and magnetic resonance imaging in the staging of rectal cancer: a prospective and comparative study.
    Fernández-Esparrach G; Ayuso-Colella JR; Sendino O; Pagés M; Cuatrecasas M; Pellisé M; Maurel J; Ayuso-Colella C; González-Suárez B; Llach J; Castells A; Ginès A
    Gastrointest Endosc; 2011 Aug; 74(2):347-54. PubMed ID: 21802588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.